BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36218378)

  • 1. Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis.
    Sugihara T; Uchida HA; Yoshifuji H; Maejima Y; Naniwa T; Katsumata Y; Okazaki T; Ishizaki J; Murakawa Y; Ogawa N; Dobashi H; Horita T; Tanaka Y; Furuta S; Takeuchi T; Komagata Y; Nakaoka Y; Harigai M
    Mod Rheumatol; 2023 Nov; 33(6):1145-1153. PubMed ID: 36218378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions.
    Sugihara T; Hasegawa H; Uchida HA; Yoshifuji H; Watanabe Y; Amiya E; Maejima Y; Konishi M; Murakawa Y; Ogawa N; Furuta S; Katsumata Y; Komagata Y; Naniwa T; Okazaki T; Tanaka Y; Takeuchi T; Nakaoka Y; Arimura Y; Harigai M; Isobe M;
    Arthritis Res Ther; 2020 Apr; 22(1):72. PubMed ID: 32264967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
    Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
    Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
    Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
    Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
    Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease pattern in cranial and large-vessel giant cell arteritis.
    Brack A; Martinez-Taboada V; Stanson A; Goronzy JJ; Weyand CM
    Arthritis Rheum; 1999 Feb; 42(2):311-7. PubMed ID: 10025926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA; Pina T
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early large vessel systemic vasculitis in adults.
    González-Gay MA; Prieto-Peña D; Martínez-Rodríguez I; Calderon-Goercke M; Banzo I; Blanco R; Castañeda S
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101424. PubMed ID: 31810548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S; Springer JM
    Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
    Iannuzzi F; Hysa E; Camellino D; Morbelli S; Bauckneht M; Sambuceti G; Cutolo M; Cimmino MA
    Clin Exp Rheumatol; 2023 Apr; 41(4):812-820. PubMed ID: 37073635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis.
    Bellan M; Puta E; Croce A; Sacchetti GM; Orsini F; Zecca E; Soddu D; Gavelli F; Avanzi GC; Castello L; Pedrazzoli R; Sola D; Pirisi M; Sainaghi PP
    Clin Rheumatol; 2020 Apr; 39(4):1277-1281. PubMed ID: 31713732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotype and complications of large vessel giant cell arteritis: A systematic review and meta-analysis.
    Lyne SA; Ruediger C; Lester S; Kaur G; Stamp L; Shanahan EM; Hill CL
    Joint Bone Spine; 2023 Jul; 90(4):105558. PubMed ID: 36858169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
    Camellino D; Matteson EL; Buttgereit F; Dejaco C
    Nat Rev Rheumatol; 2020 Sep; 16(9):481-495. PubMed ID: 32759996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-vessel giant cell arteritis: a cohort study.
    Muratore F; Kermani TA; Crowson CS; Green AB; Salvarani C; Matteson EL; Warrington KJ
    Rheumatology (Oxford); 2015 Mar; 54(3):463-70. PubMed ID: 25193809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.
    Raleigh MF; Stoddard J; Darrow HJ
    Am Fam Physician; 2022 Oct; 106(4):420-426. PubMed ID: 36260899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.